[Surveillance in children of mothers positive to hepatitis B surface antigen, 2000-2002]

Marité Bello Corredor1, Licel de los Angeles Rodriguez Lay, Graciela Delgado González

  • 1Instituto de Medicina Tropical Pedro Kouri, Apartado 601, Marianao 13, Ciudad de La Habana, Cuba. ciipk@ipk.sld.cu

Insights

Hepatitis B vaccination at birth effectively prevents perinatal infection in infants born to HBsAg-positive mothers. This surveillance program highlights high maternal positivity and significant infant seroprotection, demonstrating vaccine efficacy.

Area of Science:

  • * Hepatology and Virology
  • * Immunization and Public Health

Context:

  • * Cuba's long-standing 10-year surveillance program for perinatal Hepatitis B control.
  • * High perinatal infection risk for infants born to Hepatitis B surface antigen (HBsAg)-positive mothers.
  • * Availability of a safe and effective Hepatitis B vaccine in Cuba.

Purpose:

  • * To assess the effectiveness of a Hepatitis B vaccination program in preventing perinatal transmission.
  • * To evaluate the seropositivity rates of HBsAg in mothers and infants.
  • * To determine the seroprotection levels and vaccine efficacy in infants.

Summary:

  • * A study of 121 mother-infant pairs in Cuba found 100% HBsAg positivity in mothers.
  • * Infant HBsAg positivity was 5.7%, while seroprotection in negative infants reached 94.7% with a Geometric Mean Titer (GMT) of 233.3 UI/L.
  • * The vaccine's Efficacy Index ranged from 95.9% to 99.3%, with normoresponsive children predominating (52.6%).

Impact:

  • * Demonstrates the critical role of early detection of HBsAg-positive mothers and timely infant vaccination.
  • * Provides evidence for the high efficacy of the Hepatitis B vaccine in preventing infant infections.
  • * Supports the continuation and strengthening of national immunization programs for Hepatitis B control.